Oral bacterial cell wall, membrane, and biofilm matrix

The oral bacterial cell wall, membrane, and biofilm matrix constitute a complex structural target essential for the persistence of the oral microbiome (StatPearls: NBK549761). The cell wall and membrane provide the primary physical barrier and structural support for individual bacteria, such as Streptococcus mutans and Porphyromonas gingivalis. The biofilm matrix, or dental plaque, is an organized community of microorganisms embedded in a self-produced extracellular polymeric substance (EPS) composed of polysaccharides, proteins, and DNA (PubMed: 20802451). This matrix acts as a protective shield against host immune defenses and limits the penetration of antimicrobial agents (NIH: NIDCR). In disease states, these structures facilitate the colonization of tooth surfaces and the gingival sulcus, leading to dental caries and periodontal disease. Pharmacological agents like chlorhexidine target the bacterial membrane to cause cytoplasmic leakage, while fluoride inhibits enzymes involved in matrix production and bacterial metabolism. Antibiotics like amoxicillin target the peptidoglycan synthesis within the cell wall to induce bacterial lysis. Emerging therapies aim to specifically degrade the EPS matrix to disrupt the biofilm's physical integrity. Targeting these components is a cornerstone of preventive dentistry and the treatment of chronic oral infections.

Other names

Oral biofilmDental plaqueExtracellular polymeric substancesBacterial cell envelopeDental biofilm matrix

Drugs targeting this complex act by disrupting the lipid bilayer of the bacterial membrane, inhibiting the synthesis of peptidoglycan in the cell wall, or enzymatically degrading the extracellular polymeric substances (EPS) that form the biofilm matrix to enhance penetration of antimicrobial agents (PubMed: 20802451).